References
- Airavaara M, Mijatović J, Vihavainen T, et al. (2006). In heterozygous GDNF knockout mice the response of striatal dopaminergic system to acute morphine is altered. Synapse 59:321–9.
- Bai HW, Shim JY, Yu J, et al. (2007). Biochemical and molecular modeling studies of the O-methylation of various endogenous and exogenous catechol substrates catalyzed by recombinant human soluble and membrane-bound catechol-O-methyltransferases. Chem Res Toxicol 20:1409–25.
- Bertocci B, Miggiano V, Da Prada M, et al. (1991). Human catechol-O-methyltransferase: cloning and expression of the membrane-associated form. Proc Natl Acad Sci USA 88:1416–20.
- Guldberg HC, Marsden CA. (1975). Catechol-O-methyl transferase: pharmacological aspects and physiological role. Pharmacol Rev 27:135–206.
- Huotari M, Gogos JA, Karayiorgou M, et al. (2002). Brain catecholamine metabolism in catechol-O-methyltransferase (COMT)-deficient mice. Eur J Neurosci 15:246–56.
- Käenmäki M, Tammimäki A, García-Horsman JA, et al. (2009). Importance of membrane-bound catechol-O-methyltransferase in l-DOPA metabolism: a pharmacokinetic study in two types of Comt gene modified mice. Br J Pharmacol 158:1884–94.
- Laird PW, Zijderveld A, Linders K, et al. (1991). Simplified mammalian DNA isolation procedure. Nucleic Acids Res 19:4293.
- Lotta T, Vidgren J, Tilgmann C, et al. (1995). Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34:4202–10.
- Lundström K, Salminen M, Jalanko A, et al. (1991). Cloning and characterization of human placental catechol-O-methyltransferase cDNA. DNA Cell Biol 10:181–9.
- Männistö PT, Kaakkola S. (1999). Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev 51:593–628.
- Masuda M, Tsunoda M, Imai K. (2006). Low catechol-O-methyltransferase activity in the brain and blood pressure regulation. Biol Pharm Bull 29:202–5.
- Myöhänen TT, Männistö PT. (2010). Distribution and functions of catechol-O-methyltransferase proteins: do recent findings change the picture? Int Rev Neurobiol 95:29–47.
- Myöhänen TT, Schendzielorz N, Männistö PT. (2010). Distribution of catechol-O-methyltransferase (COMT) proteins and enzymatic activities in wild-type and soluble COMT deficient mice. J Neurochem 113:1632–43.
- Reid JJ, Stitzel RE, Head RJ. (1986). Characterization of the O-methylation of catechol oestrogens by intact rabbit thoracic aorta and subcellular fractions thereof. Naunyn Schmiedebergs Arch Pharmacol 334:17–28.
- Roth JA. (1992). Membrane-bound catechol-O-methyltransferase: a reevaluation of its role in the O-methylation of the catecholamine neurotransmitters. Rev Physiol Biochem Pharmacol 120:1–29.
- Salminen M, Lundström K, Tilgmann C, et al. (1990). Molecular cloning and characterization of rat liver catechol-O-methyltransferase. Gene 93:241–7.
- Schendzielorz N, Rysä A, Reenilä I, et al. (2011). Complex estrogenic regulation of catechol-O-methyltransferase (COMT) in rats. J Physiol Pharmacol 62:483–90.
- Tammimäki A, Aonurm-Helm A, Zhang, et al. (2016). Generation of membrane-bound catechol-O-methyl transferase deficient mice with distinct sex dependent behavioral phenotype. J Physiol Pharmacol 67:827–42.
- Tenhunen J, Salminen M, Lundström K, et al. (1994). Genomic organization of the human catechol O-methyltransferase gene and its expression from two distinct promoters. Eur J Biochem 223:1049–59.
- Tenhunen J, Salminen M, Jalanko A, et al. (1993). Structure of the rat catechol-O-methyltransferase gene: separate promoters are used to produce mRNAs for soluble and membrane-bound forms of the enzyme. DNA Cell Biol 12:253–63.
- Tenhunen J, Ulmanen I. (1993). Production of rat soluble and membrane-bound catechol O-methyltransferase forms from bifunctional mRNAs. Biochem J 296:595–600.
- Tunbridge EM, Harrison PJ. (2011). Importance of the COMT gene for sex differences in brain function and predisposition to psychiatric disorders. Curr Top Behav Neurosci 8:119–40.
- Xie T, Ho SL, Ramsden D. (1999). Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription. Mol Pharmacol 56:31–8.